Definition:SLT health
📋 SLT health — short for "similar to life techniques health" — is a classification used within the Solvency II regulatory framework to identify health insurance obligations that are underwritten and managed using actuarial methodologies analogous to those applied to life insurance business. Unlike short-term health covers that are priced annually and can be repriced or cancelled, SLT health obligations are long-term in nature, feature guaranteed renewability or level premiums, and require the insurer to model biometric risks — such as morbidity, disability duration, and recovery rates — over extended time horizons. This distinction matters because it determines which module of the Solvency Capital Requirement standard formula applies and, consequently, how the insurer must calculate its capital charge and technical provisions.
⚙️ Under Solvency II's modular structure, health underwriting risk is divided into three sub-modules: SLT health, non-SLT health, and health catastrophe risk. SLT health obligations are capitalized through stress tests that mirror life insurance risk factors — including shocks to morbidity rates, lapse assumptions, expense levels, and revision risk (the risk that benefit amounts for annuities-in-payment increase due to legal or regulatory changes). The best estimate liability for SLT health must be calculated using a cash-flow projection that discounts future benefits and premiums over the full contract boundary, incorporating assumptions about policyholder behavior and claims incidence. Products that commonly fall within SLT health include long-term disability income insurance, long-term care covers, and certain medical expense policies with lifetime guarantees. In contrast, non-SLT health covers — such as annual group medical plans or short-term accident policies — are treated using techniques closer to non-life methods, with reserve calculations based on claims triangles and premium sufficiency tests. The boundary between SLT and non-SLT can be nuanced, and national supervisors within the EEA have issued supplementary guidance to help insurers classify borderline products correctly.
📌 The SLT health designation carries significant practical consequences for insurer operations and strategy. Because SLT health products generate long-duration liabilities, the associated asset-liability management requirements resemble those of a life book rather than a general insurance portfolio, influencing investment policy and duration matching. Capital charges under the SLT health sub-module can be substantial, particularly for morbidity and lapse risk stresses, which means that an insurer's appetite for writing guaranteed-renewable health business directly affects its solvency position. For multi-line groups operating across European markets, the classification also determines how diversification benefits are calculated across the SCR's correlation matrices. While SLT health is a Solvency II–specific term, the underlying concept has broader relevance: regulators in other markets face similar challenges in determining whether health insurance liabilities should be treated as life-like or non-life-like for capital and reserving purposes, with frameworks such as C-ROSS and the ICS making comparable distinctions.
Related concepts: